Egham, UK – 18 June 2026 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of Becki Morison as Chief Executive Officer, with effect from 1 July 2026. Becki succeeds Simon Ball, who has served as interim CEO since November 2025 and will continue in his role as President of the Company’s Rare Disease business unit.